Alzamend completed a head coil to enable precise brain imaging of lithium in upcoming Phase 2 trials. Nonclinical data show AL001 improves brain absorption with lower blood levels than lithium ...

Alzamend Neuro (ALZN) announced the completion of a head coil by Tesla Dynamic Coils. The development of the head coil was necessary to facilitate the five upcoming Phase II clinical trials to be ...

On Wednesday, Alzamend Neuro, Inc. (NASDAQ:ALZN) announced it had completed the head coil by Tesla Dynamic Coils BV. The development of the head coil was necessary to facilitate Alzamend's five ...